Efzofitimod 3 mg/kg
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
aTyr Pharma, Inc.
Overview
Efzofitimod 3 mg/kg is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Efzofitimod 3 mg/kg clinical trials
Explore related
Medical disclaimer. This page summarizes research about Efzofitimod 3 mg/kg for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.